{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:29:21Z","timestamp":1773282561158,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA285013"],"award-info":[{"award-number":["U01CA285013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA285013"],"award-info":[{"award-number":["U01CA285013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA233452"],"award-info":[{"award-number":["P01CA233452"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA285013"],"award-info":[{"award-number":["U01CA285013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Provost Research Fellowship"},{"DOI":"10.13039\/100017192","name":"USC Norris Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["5P30CA014089-40"],"award-info":[{"award-number":["5P30CA014089-40"]}],"id":[{"id":"10.13039\/100017192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017192","name":"USC Norris Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["5P30CA014089-40"],"award-info":[{"award-number":["5P30CA014089-40"]}],"id":[{"id":"10.13039\/100017192","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cedars-Sinai Board of Counselors Grant"},{"name":"F.Widjaja Family Chair, the Widjaja Family Fund"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK108314"],"award-info":[{"award-number":["U01DK108314"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB032801"],"award-info":[{"award-number":["R01EB032801"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Michelson Center Convergent Science Institute in Cancer"},{"name":"Vassiliadis Research Fund"},{"name":"Vicky Joseph Research Fund"},{"name":"Hart Family Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic adenocarcinoma remains one of the most devastating cancers, with limited options for early diagnosis and outcome prediction. To address these gaps, we prospectively characterized circulating tumor cells (CTCs) and oncosomes from both the peripheral (PB) and portal vein (PoVB). A total of 121 blood samples from 39 patients (75 PB, 46 PoVB) undergoing endoscopic ultrasound were profiled using multiplex immunofluorescence and computational algorithms for rare event detection. Rare event counts were significantly elevated in pancreatic cancer patients compared to normal donors (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20094.71e-10). PoVB yielded greater numbers of epithelial and mesenchymal CTCs compared to PB, suggesting restricted systemic entry, while oncosomes were consistently detected in both compartments. Diagnostic accuracy was highest for PB oncosomes and PoVB CTCs. Importantly, PoVB mesenchymal CTCs correlated with 1-year survival (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0083), and PB oncosomes predicted poor survival (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0014). These findings highlight complementary diagnostic and prognostic value of PB oncosomes and PoVB CTCs in pancreatic cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41698-025-01165-4","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:18:13Z","timestamp":1764937093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Stephanie N.","family":"Shishido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabindra","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon K.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1165_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1165_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.suc.2009.12.003","volume":"90","author":"T Kinney","year":"2010","unstructured":"Kinney, T. Evidence-based imaging of pancreatic malignancies. Surg. Clin. North Am. 90, 235\u201349 (2010).","journal-title":"Surg. Clin. North Am."},{"key":"1165_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.suc.2010.01.002","volume":"90","author":"S Varadarajulu","year":"2010","unstructured":"Varadarajulu, S. & Eloubeidi, M. A. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg. Clin. North Am. 90, 251\u201363 (2010).","journal-title":"Surg. Clin. North Am."},{"key":"1165_CR4","unstructured":"Puckett, Y. & Garfield, K. Pancreatic cancer. in Treasure Island (FL) Ineligible Companies. Disclosure: Karen Garfield declares no relevant financial relationships with ineligible companies. (StatPearls, 2025)"},{"key":"1165_CR5","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1165_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000368089","volume":"31","author":"JH Li","year":"2014","unstructured":"Li, J. H. et al. Endoscopic ultrasonography for tumor node staging and vascular invasion in pancreatic cancer: a meta-analysis. Dig. Surg. 31, 297\u2013305 (2014).","journal-title":"Dig. Surg."},{"key":"1165_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.gcb.2010.05.004","volume":"34","author":"M Giovannini","year":"2010","unstructured":"Giovannini, M. The place of endoscopic ultrasound in bilio-pancreatic pathology. Gastroenterol. Clin. Biol. 34, 436\u201345 (2010).","journal-title":"Gastroenterol. Clin. Biol."},{"key":"1165_CR8","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.3748\/wjg.v16.i34.4253","volume":"16","author":"A Seicean","year":"2010","unstructured":"Seicean, A. Endoscopic ultrasound in chronic pancreatitis: where are we now? World J. Gastroenterol. 16, 4253\u201363 (2010).","journal-title":"World J. Gastroenterol."},{"key":"1165_CR9","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1053\/gast.2002.33576","volume":"122","author":"MF Byrne","year":"2002","unstructured":"Byrne, M. F. & Jowell, P. S. Gastrointestinal imaging: endoscopic ultrasound. Gastroenterology 122, 1631\u201348 (2002).","journal-title":"Gastroenterology"},{"key":"1165_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1572-0241.2002.05777.x","volume":"97","author":"GC Harewood","year":"2002","unstructured":"Harewood, G. C. & Wiersema, M. J. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am. J. Gastroenterol. 97, 1386\u201391 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"1165_CR11","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1053\/j.gastro.2010.06.059","volume":"139","author":"J Iglesias-Garcia","year":"2010","unstructured":"Iglesias-Garcia, J. et al. Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses. Gastroenterology 139, 1172\u201380 (2010).","journal-title":"Gastroenterology"},{"key":"1165_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0016-5107(89)72761-9","volume":"35","author":"AR Kaufman","year":"1989","unstructured":"Kaufman, A. R. & Sivak, M. V. Jr., Endoscopic ultrasonography in the differential diagnosis of pancreatic disease. Gastrointest. Endosc. 35, 214\u20139 (1989).","journal-title":"Gastrointest. Endosc."},{"key":"1165_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0016-5107(01)70401-4","volume":"53","author":"MB Wallace","year":"2001","unstructured":"Wallace, M. B. et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest. Endosc. 53, 294\u20139 (2001).","journal-title":"Gastrointest. Endosc."},{"key":"1165_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09387-6","volume":"22","author":"L Sivapalan","year":"2022","unstructured":"Sivapalan, L. et al. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer. BMC Cancer 22, 369 (2022).","journal-title":"BMC Cancer"},{"key":"1165_CR15","unstructured":"Vietsch, E. E., C. H. van Eijck & Wellstein, A. Circulating DNA and micro-RNA in patients with pancreatic cancer. Pancreat. Disord. Ther. 5, 156 (2015)."},{"key":"1165_CR16","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdz200","volume":"30","author":"B Lee","year":"2019","unstructured":"Lee, B. et al. Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer. Ann. Oncol. 30, 1472\u20131478 (2019).","journal-title":"Ann. Oncol."},{"key":"1165_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/07357907.2014.1001894","volume":"33","author":"N Singh","year":"2015","unstructured":"Singh, N. et al. High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival. Cancer Investig. 33, 78\u201385 (2015).","journal-title":"Cancer Investig."},{"key":"1165_CR18","doi-asserted-by":"publisher","first-page":"e0235623","DOI":"10.1371\/journal.pone.0235623","volume":"15","author":"Y Uesato","year":"2020","unstructured":"Uesato, Y. et al. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis. PLoS ONE 15, e0235623 (2020).","journal-title":"PLoS ONE"},{"key":"1165_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1158\/2159-8290.CD-15-0274","volume":"5","author":"OA Zill","year":"2015","unstructured":"Zill, O. A. et al. Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov. 5, 1040\u20138 (2015).","journal-title":"Cancer Discov."},{"key":"1165_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bjc.2016.121","volume":"114","author":"JS Ankeny","year":"2016","unstructured":"Ankeny, J. S. et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Br. J. Cancer 114, 1367\u201375 (2016).","journal-title":"Br. J. Cancer"},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pan.2020.11.022","volume":"21","author":"TCY Pang","year":"2021","unstructured":"Pang, T. C. Y. et al. Circulating tumour cells in pancreatic cancer: a systematic review and meta-analysis of clinicopathological implications. Pancreatology 21, 103\u2013114 (2021).","journal-title":"Pancreatology"},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s13277-013-1327-5","volume":"35","author":"L Han","year":"2014","unstructured":"Han, L., Chen, W. & Zhao, Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumour Biol. 35, 2473\u201380 (2014).","journal-title":"Tumour Biol."},{"key":"1165_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00521-0","volume":"8","author":"SN Shishido","year":"2024","unstructured":"Shishido, S. N. et al. Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. npj Precis. Oncol. 8, 36 (2024).","journal-title":"npj Precis. Oncol."},{"key":"1165_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000177022","volume":"26","author":"MA Eloubeidi","year":"2008","unstructured":"Eloubeidi, M. A. & Tamhane, A. Prospective assessment of diagnostic utility and complications of endoscopic ultrasound-guided fine needle aspiration. Results from a newly developed academic endoscopic ultrasound program. Dig. Dis. 26, 356\u201363 (2008).","journal-title":"Dig. Dis."},{"key":"1165_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4251\/wjgo.v15.i4.632","volume":"15","author":"SW Ko","year":"2023","unstructured":"Ko, S. W. & Yoon, S. B. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World J. Gastrointest. Oncol. 15, 632\u2013643 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"key":"1165_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.pan.2020.10.039","volume":"20","author":"CG Chapman","year":"2020","unstructured":"Chapman, C. G. et al. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers. Pancreatology 20, 1747\u20131754 (2020).","journal-title":"Pancreatology"},{"key":"1165_CR27","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1053\/j.gastro.2015.08.050","volume":"149","author":"DV Catenacci","year":"2015","unstructured":"Catenacci, D. V. et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology 149, 1794\u20131803.e4 (2015).","journal-title":"Gastroenterology"},{"key":"1165_CR28","doi-asserted-by":"crossref","unstructured":"Gerdtsson, A. S. et al. Large extracellular vesicle characterization and association with circulating tumor cells in metastatic castrate resistant prostate cancer. Cancers 13, 1056 (2021).","DOI":"10.3390\/cancers13051056"},{"key":"1165_CR29","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ajpath.2012.07.030","volume":"181","author":"D Di Vizio","year":"2012","unstructured":"Di Vizio, D. et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am. J. Pathol. 181, 1573\u201384 (2012).","journal-title":"Am. J. Pathol."},{"key":"1165_CR30","doi-asserted-by":"publisher","first-page":"11327","DOI":"10.18632\/oncotarget.3598","volume":"6","author":"VR Minciacchi","year":"2015","unstructured":"Minciacchi, V. R. et al. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles. Oncotarget 6, 11327\u201341 (2015).","journal-title":"Oncotarget"},{"key":"1165_CR31","doi-asserted-by":"crossref","unstructured":"Narayan, S., et al. Defining a liquid biopsy profile of circulating tumor cells and oncosomes in metastatic colorectal cancer for clinical utility. Cancers 14, 758 (2022).","DOI":"10.3390\/cancers14194891"},{"key":"1165_CR32","doi-asserted-by":"crossref","unstructured":"Shishido, S. N. et al. Characterization of cellular and acellular analytes from pre-cystectomy liquid biopsies in patients newly diagnosed with primary bladder cancer. Cancers 14, 758 (2022).","DOI":"10.3390\/cancers14030758"},{"key":"1165_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/biomedicines10061289","volume":"10","author":"YH Choi","year":"2022","unstructured":"Choi, Y. H. et al. Prognostic implications of portal venous circulating tumor cells in resectable pancreatic cancer. Biomedicines 10, 1289 (2022).","journal-title":"Biomedicines"},{"key":"1165_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-025-05669-x","volume":"82","author":"D Yeo","year":"2025","unstructured":"Yeo, D. et al. Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancer. Cell Mol. Life Sci. 82, 155 (2025).","journal-title":"Cell Mol. Life Sci."},{"key":"1165_CR35","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1245\/s10434-020-09518-y","volume":"28","author":"MG White","year":"2021","unstructured":"White, M. G. et al. Measurement of portal vein blood circulating tumor cells is safe and may correlate with outcomes in resected pancreatic ductal adenocarcinoma. Ann. Surg. Oncol. 28, 4615\u20134622 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"1165_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/gut.30.4.503","volume":"30","author":"HS Brown","year":"1989","unstructured":"Brown, H. S. et al. Measurement of normal portal venous blood flow by Doppler ultrasound. Gut 30, 503\u20139 (1989).","journal-title":"Gut"},{"key":"1165_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jcu.1870140802","volume":"14","author":"F Moriyasu","year":"1986","unstructured":"Moriyasu, F. et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J. Clin. Ultrasound 14, 579\u201388 (1986).","journal-title":"J. Clin. Ultrasound"},{"key":"1165_CR38","unstructured":"Rocha, F. G. in Liver blood flow: Physiology, measurement, and clinical relevance, in Blumgart\u2019s Surgery of the Liver, Pancreas and Biliary Tract 5th edn (eds Jarnagin, W. R. & Blumgart, L. H.) Ch. 4 (W.B. Saunders, 2012)."},{"key":"1165_CR39","doi-asserted-by":"publisher","first-page":"AB336","DOI":"10.1016\/j.gie.2020.03.2181","volume":"91","author":"KH Park","year":"2020","unstructured":"Park, K. H. et al. Su1335 feasibility and safety of using a 22-gauge endoscopic ultrasound needle for portal vein sampling in a swine model. Gastrointest. Endosc. 91, AB336\u2013AB337 (2020).","journal-title":"Gastrointest. Endosc."},{"key":"1165_CR40","doi-asserted-by":"publisher","first-page":"016003","DOI":"10.1088\/1478-3975\/9\/1\/016003","volume":"9","author":"D Marrinucci","year":"2012","unstructured":"Marrinucci, D. et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys. Biol. 9, 016003 (2012).","journal-title":"Phys. Biol."},{"key":"1165_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.5858\/arpa.2016-0483-OA","volume":"142","author":"M Rodriguez-Lee","year":"2018","unstructured":"Rodriguez-Lee, M. et al. Effect of blood collection tube type and time to processing on the enumeration and high-content characterization of circulating tumor cells using the high-definition single-cell assay. Arch. Pathol. Lab. Med. 142, 198\u2013207 (2018).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1165_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmoldx.2019.11.006","volume":"22","author":"SN Shishido","year":"2020","unstructured":"Shishido, S. N. et al. Preanalytical variables for the genomic assessment of the cellular and acellular fractions of the liquid biopsy in a cohort of breast cancer patients. J. Mol. Diagn. 22, 319\u2013337 (2020).","journal-title":"J. Mol. Diagn."},{"key":"1165_CR43","doi-asserted-by":"crossref","unstructured":"Chai, S. et al. Platelet-coated circulating tumor cells are a predictive biomarker in patients with metastatic castrate resistant prostate cancer. Mol. Cancer Res. 19, 2036\u20132045 (2021).","DOI":"10.1158\/1541-7786.MCR-21-0383"},{"key":"1165_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00289-1","volume":"6","author":"S Chai","year":"2022","unstructured":"Chai, S. et al. Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case. NPJ Precis. Oncol. 6, 41 (2022).","journal-title":"NPJ Precis. Oncol."},{"key":"1165_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00480-4","volume":"8","author":"SM Setayesh","year":"2022","unstructured":"Setayesh, S. M. et al. Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer. NPJ Breast Cancer 8, 112 (2022).","journal-title":"NPJ Breast Cancer"},{"key":"1165_CR46","doi-asserted-by":"crossref","unstructured":"Shishido, S. N. et al. Liquid biopsy landscape in patients with primary upper tract urothelial carcinoma. Cancers 14, 3007 (2022).","DOI":"10.3390\/cancers14123007"},{"key":"1165_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43856-025-01024-0","volume":"5","author":"N Higa","year":"2025","unstructured":"Higa, N. et al. Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer. Commun. Med. 5, 309 (2025).","journal-title":"Commun. Med."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01165-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:57:10Z","timestamp":1765807030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01165-4","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The HDSCA technology described here is licensed to Epic Sciences. P.K. has ownership in Epic Sciences. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}